Key points are not available for this paper at this time.
A T helper cell type 1–mediated colitis develops in severe combined immunodeficient mice after transfer of CD45RBhigh CD4+ T cells and can be prevented by cotransfer of the CD45RBlow subset. The immune-suppressive activities of the CD45RBlow T cell population can be reversed in vivo by administration of an anti-transforming growth factor β antibody. Here we show that interleukin (IL)-10 is an essential mediator of the regulatory functions of the CD45RBlow population. This population isolated from IL-10–deficient (IL-10−/−) mice was unable to protect from colitis and when transferred alone to immune-deficient recipients induced colitis. Treatment with an anti–murine IL-10 receptor monoclonal antibody abrogated inhibition of colitis mediated by wild-type (WT) CD45RBlow CD4+ cells, suggesting that IL-10 was necessary for the effector function of the regulatory T cell population. Inhibition of colitis by WT regulatory T cells was not dependent on IL-10 production by progeny of the CD45RBhigh CD4+ cells, as CD45RBlow CD4+ cells from WT mice were able to inhibit colitis induced by IL-10−/− CD45RBhigh CD4+ cells. These findings provide the first clear evidence that IL-10 plays a nonredundant role in the functioning of regulatory T cells that control inflammatory responses towards intestinal antigens.
Building similarity graph...
Analyzing shared references across papers
Loading...
Chrystelle Asseman
La Jolla Institute for Immunology
Smita Mauze
Merck & Co., Inc., Rahway, NJ, USA (United States)
Michael W. Leach
Trident Systems (United States)
The Journal of Experimental Medicine
University of Oxford
John Radcliffe Hospital
Cellular Research (United States)
Building similarity graph...
Analyzing shared references across papers
Loading...
Asseman et al. (Mon,) studied this question.
synapsesocial.com/papers/698d2fd30e3f60712276e92e — DOI: https://doi.org/10.1084/jem.190.7.995